133 KB48 KB199420252009Vidmar, VesnaZabukovec, Marinaštevilka:4letnik:48str. 313-325ISSN:0025-8121COBISSID:26480601URN:URN:NBN:SI:doc-QYGIU60UslMedicinski razglediMedicinski razglediApoptosisApoptozaAutoimmune DiseasesAvtoimunske bolezniDiagnosisEncimsko-vezani imunosorbentni testEnzyme-Linked Immunosorbent AssayFlow CytometryGeneticsgenetikaImmunologyimunologijaInterleukin-10Interlevkin-10LimfadenitisLimfocitni podtipiLimfoproliferativne motnjeLymphadenitisLymphocyte SubsetsLymphoproliferative DisordersPretočna citometrijaRetrospective StudiesRetrospektivne študijeSplenomegalijaSplenomegalyKlinične, imunološke in genetske značilnosti bolnikov z avtoimunskim limfoproliferativnim sindromom v Sloveniji| Clinical, immunological and genetic characteristics of patients with autoimmune lymphoproliferative syndrome in Slovenia|Background: Autoimmune lymphoproliferative syndrome (ALPS) is a primary immunodeficiency disorder characterized by immune dysregulation. ALPS is defined as chronic, nonmalignant lymphoproliferation in patients with double-negative T cell (DNT) expansion over 1 % and defective lymphocyte apoptosis. The etiology of the disease has not been fuliy explained;the spectrum of its dinical manifestations is broad and the exact diagnostic criteria have not yet been established. AIM. Our goal was to define the clinical, immunological and genetic background of ALPS patients in our country. Methods: The study included all patients under suspicion of ALPS treated at the University Children's Hospital in Ljubljana. The criteria established by the investigators were: age under 18 years and presence of at least one clinical manifestation and at least one immunological finding characteristic for ALPS. The study was retrospective and involved areview of dinical documentation. Information about dinical, immunological and laboratoryfindings was collected for every patient, from the time of first presentation of the disease. The patients were followed up to the last clinical examination. At the Institute of Microbiology and Immunology, lymphocyte subtypes were quantified by flow cytometry, serum values ofIL-lO were evaluated using the ELISA method, and apoptotic cell death was assessed. At the genetic laboratory, the nudeotide sequences of the Fas gene which encodes Fas protein and Fas ligand gene were analysed. Results: The study included 11 patients. Three of them fulfllled all diagnostic criteria for ALPS. The other 8 patients fulfilled the criteria determined by the investigators. This means that they had one dinical and one laboratory findingcharacteristic for ALPS, but did not fulfil all of the criteria needed for the diagnosis of ALPS. Conclusion: ALPS is a variable clinical condition with manifestations that can present later in life. (Abstract truncated at 20TEXTznanstveno časopisjejournalsSlovenian National E-content AggregatorNational and University Library of SloveniaDruštvo Medicinski razgledi